BeOne Medicines (ONC) Equity Ratio: 2015-2025
Historic Equity Ratio for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 0.54.
- BeOne Medicines' Equity Ratio fell 8.19% to 0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54, marking a year-over-year decrease of 8.19%. This contributed to the annual value of 0.56 for FY2024, which is 7.64% down from last year.
- BeOne Medicines' Equity Ratio amounted to 0.54 in Q3 2025, which was down 9.63% from 0.60 recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Equity Ratio registered a high of 0.80 during Q4 2022, and its lowest value of 0.54 during Q3 2025.
- In the last 3 years, BeOne Medicines' Equity Ratio had a median value of 0.60 in 2025 and averaged 0.61.
- As far as peak fluctuations go, BeOne Medicines' Equity Ratio rose by 11.31% in 2022, and later fell by 23.81% in 2023.
- Over the past 5 years, BeOne Medicines' Equity Ratio (Quarterly) stood at 0.72 in 2021, then rose by 11.31% to 0.80 in 2022, then declined by 23.81% to 0.61 in 2023, then dropped by 7.64% to 0.56 in 2024, then decreased by 8.19% to 0.54 in 2025.
- Its Equity Ratio was 0.54 in Q3 2025, compared to 0.60 in Q2 2025 and 0.60 in Q1 2025.